Shandong Sito Bio-technology Co., Ltd. (SHE:300583)

China · Delayed Price · Currency is CNY

12.28

+0.05 (0.41%)

Aug 4, 2026, 3:04 PM CST

-35.87% (1Y)

Market Cap	2.33B -35.9%
Revenue (ttm)	1.09B +10.0%
Net Income	-42.02M
EPS	-0.22
Shares Out	189.70M
PE Ratio	n/a
Forward PE	n/a
Dividend	0.02 (0.12%)
Ex-Dividend Date	Jul 14, 2026

Volume	2,771,880
Open	12.25
Previous Close	12.23
Day's Range	12.19 - 12.42
52-Week Range	10.63 - 19.18
Beta	0.11
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 25, 2026

About SHE:300583

Shandong Sito Bio-technology Co., Ltd. researches, develops, and produces steroid biomedicine intermediates. Its products include 9α-hydroxyandrost, 17α-hydroxyprogesterone, 17α-hydroxy progesterone derivatives, anecort acetate, bis-decyl alcohol (BA), neomycin sulfate, progesterone intermediate, tylvalosin tartrate, tetraene acetate, androstenedione, bisnoralcohol, norandrostenedione, 16β and 16α methyl epoxide, and hexahydro-3a-methyl, as well as androsta-1,4-diene-3,17-dione and estra-4,9-diene-3,17-dione. It also provides APIs for animal he... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2002

Employees 990

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 300583

Full Company Profile

Financial Performance

In 2025, SHE:300583's revenue was 1.02 billion, an increase of 4.77% compared to the previous year's 970.60 million. Losses were -73.15 million, -17.60% less than in 2024.

Financial Statements